Tech Insider In Exclusive Interview: “Why Elon Musk May Have No Choice but to Unlock Billions Through a Starlink Spinoff” In a recent presentation, James Altucher predicts that Musk's financial pressures could spark one of the most significant business moves of the decade GlobeNewswire October 03, 2025 Washington, D.C., Oct. 03, 2025 (GLOBE NEWSWIRE) — […]
Anathapindika Health's Detoxifying Supplements Are Headed to Retailers in the US The Company's Name Comes From Its Root Cause: to Provide Effective, Natural Solutions to Those Battling Health Issues. Soon, American Consumers Will Have Access to Those Solutions. GlobeNewswire October 03, 2025 Fort Lauderdale, FL, Oct. 03, 2025 (GLOBE NEWSWIRE) — Anathapindika Health is an
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025 GlobeNewswire October 03, 2025 SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its proprietary CAB platform for the
Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025 GlobeNewswire October 03, 2025 Oxford, United Kingdom – October 3, 2025. Enara Bio, a biopharmaceutical company pioneering the discovery of novel Dark Antigens(R) and the development of bispecific T cell engagers for solid tumors, will
STMicroelectronics announces timing for third quarter 2025 earnings release and conference call GlobeNewswire October 03, 2025 STMicroelectronics announces timing for third quarter 2025 earnings release and conference call Geneva – October 3, 2025 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced that it will release third
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting GlobeNewswire October 03, 2025 WALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple upcoming poster presentations at
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting GlobeNewswire October 03, 2025 WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system
California Resources Corporation Schedules Third Quarter 2025 Earnings Conference Call GlobeNewswire October 03, 2025 LONG BEACH, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) plans to release its third quarter 2025 financial results on Tuesday, November 4th after market close. The Company will hold a conference call to discuss these financial
Anathapindika Is Bringing Holistic Health to the US Through a Trio of Unconventional Nutraceutical Formulas Anthapindika Health's Flagship Product Bundle Addresses Overall Health and Well-Being Through Comprehensive Detoxing and Cleansing GlobeNewswire October 03, 2025 Fort Lauderdale, FL, Oct. 03, 2025 (GLOBE NEWSWIRE) — Anathapindika Health has been gaining a following in South Korea through its
Patrimonio en Fideicomiso–D. Leg. No. 861, No Inscrito en la SMV, Dirigido a Inversionistas Institucionales-InRetail Shopping Malls, a Peruvian trust, acting through its trustee, Internacional de Títulos Sociedad Titulizadora S.A. (the “Company,” or “InRetail Shopping Malls”) announced today that it has commenced a tender offer for cash (the “Tender Offer”) for any and all of